Merck & Co., Inc. (MRK) News Today → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free MRK Stock Alerts $124.53 -1.37 (-1.09%) (As of 05:27 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30 at 4:47 PM | marketbeat.comTreasurer of the State of North Carolina Has $136.24 Million Stake in Merck & Co., Inc. (NYSE:MRK)Treasurer of the State of North Carolina increased its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,249,641 shares of the company's stock afteMay 30 at 2:45 PM | cnbc.comHealthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conferenceMay 30 at 7:26 AM | americanbankingnews.comMerck & Co., Inc. (MRK) To Go Ex-Dividend on June 17thMay 29 at 11:45 PM | marketbeat.comCatalytic Wealth RIA LLC Takes $1.15 Million Position in Merck & Co., Inc. (NYSE:MRK)Catalytic Wealth RIA LLC acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 10,538 shares of the company's stock, valued at approximately $1,149,May 29 at 8:01 PM | businesswire.comMerck Signs MoU with KAIST to Advance Scientific CollaborationMay 29 at 5:57 PM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Declares $0.77 Quarterly DividendMerck & Co., Inc. (NYSE:MRK) announced a quarterly dividend on Wednesday, May 29th. Shareholders of record on Monday, June 17th will be paid a dividend of 0.77 per share on Monday, July 8th. This represents a $3.08 annualized dividend and a yield of 2.45%. The ex-dividend date is Monday, June 17th.May 29 at 4:06 PM | proactiveinvestors.comMerck acquires EyeBio in up to $3B dealMay 29 at 3:26 PM | markets.businessinsider.comMerck To Acquire EyeBio; Deal Valued Up To $3 BlnMay 29 at 3:26 PM | msn.comM&A: Merck (MRK) Nears Deal to Bolster Eye-care PortfolioMay 29 at 10:26 AM | msn.comMerck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBioMay 29 at 10:26 AM | msn.comMerck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)May 29 at 10:26 AM | msn.comMerck to buy eye-care startup EyeBio for up to $3B - reportMay 29 at 10:26 AM | finance.yahoo.comMerck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBioMay 29 at 10:26 AM | finance.yahoo.comFDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural MesotheliomaMay 29 at 8:44 AM | barrons.comMerck to Buy Eye Drug Startup For Up to $3 Billion. It's Doubling Down on Deals.May 29 at 7:15 AM | businesswire.comFDA Grants Priority Review to Merck's Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural MesotheliomaMay 29 at 7:02 AM | reuters.comMerck to acquire eye drug company EyeBio for up to $3 blnMay 29 at 6:45 AM | businesswire.comMerck to Acquire EyeBioMay 28 at 11:13 PM | finance.yahoo.comMerck nears $1.3 bln takeover of Eyebiotech- WSJMay 28 at 11:13 PM | finance.yahoo.comMerck Nears $1.3 Billion Deal for Eye-Drug Company EyeBioMay 28 at 11:13 PM | finance.yahoo.comMerck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reportsMay 28 at 9:26 PM | reuters.comMerck nears $1.3 bln cash deal for eye-drug company EyeBio, WSJ reportsMay 28 at 4:49 PM | marketbeat.comStifel Financial Corp Reduces Stock Position in Merck & Co., Inc. (NYSE:MRK)Stifel Financial Corp trimmed its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 0.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,797,451 shares of the company's stock after selling 37,183 sMay 28 at 3:12 PM | businesswire.comMerck Announces Third-Quarter 2024 DividendMay 28 at 12:56 PM | msn.comMerck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Lung Cancer StudyMay 28 at 7:55 AM | finance.yahoo.comIs Merck & Co., Inc.'s (NYSE:MRK) Recent Performance Underpinned By Weak Financials?May 28 at 6:45 AM | businesswire.comMerck Announces Phase 3 KEYNOTE-522 Trial Met its Overall Survival (OS) Endpoint in Patients With High-Risk Early-Stage Triple Negative Breast Cancer (TNBC)May 27 at 9:28 PM | marketbeat.comEdmond DE Rothschild Holding S.A. Cuts Stock Position in Merck & Co., Inc. (NYSE:MRK)Edmond DE Rothschild Holding S.A. lessened its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 31.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 167,092 shares of the company's stock after sellinMay 27 at 3:00 PM | finance.yahoo.comHedge Funds Are Loading Up On This Dividend StockMay 26, 2024 | marketbeat.comCantor Fitzgerald Investment Advisors L.P. Makes New $20.72 Million Investment in Merck & Co., Inc. (NYSE:MRK)Cantor Fitzgerald Investment Advisors L.P. bought a new stake in Merck & Co., Inc. (NYSE:MRK - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 190,073 shares of the company's stock, valued at approximately $20,722May 26, 2024 | marketbeat.comQuilter Plc Increases Holdings in Merck & Co., Inc. (NYSE:MRK)Quilter Plc raised its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 3.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 876,878 shares of the company's stock after purcMay 25, 2024 | investors.comS&P 500 Plays And One Dow Jones Giant Lead Five Stocks Near Buy PointsMay 25, 2024 | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Johnson Financial Group Inc.Johnson Financial Group Inc. decreased its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 25.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 20,822 shares of the company's stock after selling 6,932 shares during thMay 24, 2024 | fool.comBillionaire Ken Griffin Is Buying These Dividend Stocks Hand Over Fist. Should You?May 23, 2024 | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Purchased by Leavell Investment Management Inc.Leavell Investment Management Inc. increased its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 25.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,579 shares of the company's stock after pMay 23, 2024 | reuters.comHPV vaccine provides real benefits for men, analysis showsMay 23, 2024 | investorplace.comBargain Bin: 3 Cheap Stocks to Buy Before Memorial DayMay 22, 2024 | marketbeat.comJPL Wealth Management LLC Purchases Shares of 14,066 Merck & Co., Inc. (NYSE:MRK)JPL Wealth Management LLC purchased a new stake in Merck & Co., Inc. (NYSE:MRK - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 14,066 shares of the company's stock, valued at approximaMay 22, 2024 | finance.yahoo.comMerck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%May 22, 2024 | marketbeat.comV Square Quantitative Management LLC Grows Stake in Merck & Co., Inc. (NYSE:MRK)V Square Quantitative Management LLC boosted its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 25.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,745 shares of the company's stock after bMay 20, 2024 | marketbeat.comFranklin Resources Inc. Grows Stock Position in Merck & Co., Inc. (NYSE:MRK)Franklin Resources Inc. raised its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 6.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 10,114,295 shares of the company's stock after buying an additional 617,022 shares during the period.May 20, 2024 | finance.yahoo.comThe Zacks Analyst Blog Highlights Stocks recently featured in the blog include: American Express, Walmart, Amazon, The Goldman Sachs and Merck & CoMay 20, 2024 | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Acquired by Gladstone Institutional Advisory LLCGladstone Institutional Advisory LLC lifted its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 24.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 94,642 shares of the company's stock after purchasMay 18, 2024 | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Purchased by Applied Finance Capital Management LLCApplied Finance Capital Management LLC increased its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 11.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 152,919 shares of the company's stock after aMay 18, 2024 | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Princeton Capital Management LLCPrinceton Capital Management LLC reduced its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 27.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,167 shares of the compaMay 17, 2024 | finance.yahoo.comInsiders At Merck Sold US$12m In Stock, Alluding To Potential WeaknessMay 17, 2024 | marketbeat.comQ2 2024 EPS Estimates for Merck & Co., Inc. Lifted by Analyst (NYSE:MRK)Merck & Co., Inc. (NYSE:MRK - Free Report) - Stock analysts at Zacks Research boosted their Q2 2024 earnings estimates for Merck & Co., Inc. in a research report issued on Wednesday, May 15th. Zacks Research analyst S. Ganoria now forecasts that the company will post earnings of $2.10 per share fMay 17, 2024 | investorplace.comStorm Shelter: 7 Safe Haven Stocks to Batten Down the HatchesMay 16, 2024 | cnbc.comCramer says these 10 stocks helped the Dow briefly crack 40,000May 16, 2024 | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Capital Wealth Planning LLCCapital Wealth Planning LLC lessened its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 27.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,513,495 shares of the company's stock after selling Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address The only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral. Stream the documentary for free by clicking here MRK Media Mentions By Week MRK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.550.80▲Average Medical News Sentiment MRK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼3716▲MRK Articles Average Week Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eli Lilly and Company News Johnson & Johnson News AbbVie News Pfizer News Bristol-Myers Squibb News Zoetis News Royalty Pharma News Jazz Pharmaceuticals News Perrigo News Corcept Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MRK) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm PressThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
